Advances in molecular mechanisms of liver ischemia reperfusion injury

doi:10.3877/cma.j.issn.1674-3903.2018.04.011

Abstract

Abstract:

Ischemia reperfusion injury (IRI) represents the main cause of liver damage during surgical procedures such as hepatic resection and liver transplantation, it is an inevitable process of liver transplantation, which may lead to liver function failure and affect the postoperative short-term and long-term efficacy of liver transplant recipients. The molecular mechanisms occurring during hepatic ischemia reperfusion are largely unknown and keeping update. This review aims to summarize some significant molecular mechanisms in research progress of liver IRI. In addition, some new strategies for alleviating IRI are outlined to provide theoretical and scientific basis for clinical improvement of postoperative graft survival rate and liver transplantation curative effect.

Key words: Ischemia reperfusion injury, Molecular mechanism, Liver, Liver transplantation

Chin-Hui Lai, Zhongzhong Liu, Ling Li, Zibiao Zhong, Shaojun Ye, Yanfeng Wang, Qifa Ye. Advances in molecular mechanisms of liver ischemia reperfusion injury[J]. Chinese Journal of Transplantation(Electronic Edition), 2018, 12(04): 188-192.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhyzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3903.2018.04.011

https://zhyzzz.cma-cmc.com.cn/EN/Y2018/V12/I04/188

References 41

1	Ikeda T, Yanaga K, Kishikawa K, et al. Ischemic injury in liver transplantation: difference in injury sites between warm and cold ischemia in rats[J]. Hepatology, 1992, 16(2):454-461.
2	Zhai Y, Busuttil RW, Kupiec-Weglinski JW. Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation[J]. Am J Transplant, 2011, 11(8): 1563-1569.
3	Zhai Y, Petrowsky H, Hong JC, et al. Ischaemia-reperfusion injury in liver transplantation-from bench to bedside[J]. Nat Rev Gastroenterol Hepatol, 2013, 10(2): 79-89.
4	Lentsch AB, Kato A, Yoshidome H, et al. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury[J]. Hepatology, 2000, 32(2):169-173.
5	Tsung A, Klune JR, Zhang X, et al. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling[J]. J Exp Med, 2007, 204(12):2913-2923.
6	Jaeschke H. Mechanisms of reperfusion injury after warm ischemia of the liver[J]. J Hepatobiliary Pancreat Surg, 1998, 5(4):402-408.
7	Bahde R, Spiegel HU. Hepatic ischaemia-reperfusion injury from bench to bedside[J]. Br J Surg, 2010, 97(10):1461-1475.
8	Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury: Present concepts[J]. J Gastroenterol Hepatol, 2011, 26(Suppl 1):173-179.
9	Hide D, Ortega-Ribera M, Garcia-Pagan JC, et al. Effects of warm ischemia and reperfusion on the liver microcirculatory phenotype of rats: underlying mechanisms and pharmacological therapy[J]. Sci Rep, 2016, 6:22107.
10	Csak T, Velayudham A, Hritz I, et al. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice[J]. Am J Physiol Gastrointest Liver Physiol, 2011, 300(3):G433-G441.
11	Nayak L, Lin Z, Jain MK. "Go with the flow" ：how Kruppel-like factor 2 regulates the vasoprotective effects of shear stress[J]. Antioxid Redox Signal, 2011, 15(5):1449-1461.
12	Gracia-Sancho J, Villarreal G Jr, Zhang Y, et al. Flow cessation triggers endothelial dysfunction during organ cold storage conditions: strategies for pharmacologic intervention[J]. Transplantation, 2010, 90(2):142-149.
13	Liu Z, Zhang X, Xiao Q, et al. Pretreatment donors after circulatory death with simvastatin alleviates liver ischemia reperfusion injury through a KLF2-dependent mechanism in rat[J]. Oxid Med Cell Longev, 2017：3861914.
14	Klune JR, Tsung A. Molecular biology of liver ischemia/reperfusion injury: established mechanisms and recent advancements[J]. Surg Clin North Am, 2010, 90(4):665-677.
15	Tsung A, Sahai R, Tanaka H, et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion[J]. J Exp Med, 2005, 201(7):1135- 1143.
16	Cursio R, Colosetti P, Gugenheim J. Gugenheim, Autophagy and liver ischemia-reperfusion injury[J]. Biomed Res Int, 2015：417590.
17	Chouchani ET, Pell VR, James AM, et al. A unifying mechanism for mitochondrial superoxide production during ischemia-reperfusion injury[J]. Cell Metab, 2016, 23(2):254-263.
18	Reddy NM, Kleeberger SR, Kensler TW, et al. Correction: disruption of Nrf2 impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice[J]. J Immunol, 2017, 198(9):3755.
19	Huang J, Yue S, Ke B, et al. Nuclear factor erythroid 2-related factor 2 regulates toll-like receptor 4 innate responses in mouse liver ischemia-reperfusion injury through Akt-forkhead box protein O1 signaling network[J]. Transplantation, 2014, 98(7):721-728.
20	Sun J, Wu Q, Sun H, et al. Inhibition of histone deacetylase by butyrate protects rat liver from ischemic reperfusion injury[J]. Int J Mol Sci, 2014, 15(11):21069-21079.
21	Kato H, Kuriyama N, Duarte S, et al. MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury[J]. J Hepatol, 2014, 60(5):1032-1039.
22	Zhang C, Liao Y, Li Q, et al. Recombinant adiponectin ameliorates liver ischemia reperfusion injury via activating the AMPK/eNOS pathway[J]. PLoS One, 2013, 8(6):e66382.
23	Massip-Salcedo M, Zaouali MA, Padrissa-Altés S, et al. Activation of peroxisome proliferator-activated receptor-alpha inhibits the injurious effects of adiponectin in rat steatotic liver undergoing ischemia-reperfusion[J]. Hepatology, 2008, 47(2):461-472.
24	Elias-Miró M, Massip-Salcedo M, Raila J, et al. Retinol binding protein 4 and retinol in steatotic and nonsteatotic rat livers in the setting of partial hepatectomy under ischemia/reperfusion[J]. Liver Transpl, 2012, 18(10):1198-1208.
25	Elias-Miró M, Mendes-Braz M, Cereijo R, et al. Resistin and visfatin in steatotic and non-steatotic livers in the setting of partial hepatectomy under ischemia-reperfusion[J]. J Hepatol, 2014, 60(1): 87-95.
26	Zhang XJ, Cheng X, Yan ZZ, et al. An ALOX12-12-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury[J]. Nat Med, 2018, 24(1):73-83.
27	Shen XD, Ke B, Zhai Y, et al. Absence of toll-like receptor 4 (TLR4) signaling in the donor organ reduces ischemia and reperfusion injury in a murine liver transplantation model[J]. Liver Transpl, 2007, 13(10):1435-1443.
28	Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants？[J]. J Leukoc Biol, 2010, 87(6):989-999.
29	Tsung A, Klune JR, Zhang X, et al. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling[J]. J Exp Med, 2007, 204(12):2913-2923.
30	Dhupar R, Klune JR, Evankovich J, et al. Interferon regulatory factor 1 mediates acetylation and release of high mobility group box 1 from hepatocytes during murine liver ischemia-reperfusion injury[J]. Shock, 2011, 35(3):293-301.
31	Schiraldi M, Raucci A, Muñoz LM, et al. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4[J]. J Exp Med, 2012, 209(3):551-563.
32	McDonald B, Pittman K, Menezes GB, et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation[J]. Science, 2010, 330(6002):362-366.
33	Zhu P, Duan L, Chen J, et al. Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice[J]. Hum Gene Ther, 2011, 22(7):853-864.
34	Cursio R, Colosetti P, Gugenheim J. Autophagy and liver ischemia-reperfusion injury[J]. Biomed Res Int, 2015：417590.
35	Gracia-Sancho J, Guixé-Muntet S, Hide D, et al. Modulation of autophagy for the treatment of liver diseases[J]. Expert Opin Investig Drugs, 2014, 23(7):965-977.
36	Minor T, Stegemann J, Hirner A, et al. Impaired autophagic clearance after cold preservation of fatty livers correlates with tissue necrosis upon reperfusion and is reversed by hypothermic reconditioning[J]. Liver Transpl, 2009, 15(7):798-805.
37	Guixé-Muntet S, de Mesquita FC, Vila S, et al. Cross-talk between autophagy and KLF2 determines endothelial cell phenotype and microvascular function in acute liver injury[J]. J Hepatol, 2017, 66(1):86-94.
38	Farid WR, Pan Q, van der Meer AJ, et al. Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation[J]. Liver Transpl, 2012, 18(3):290-297.
39	Kim KH, Dhupar R, Ueki S, et al. Donor graft interferon regulatory factor-1 gene transfer worsens liver transplant ischemia/reperfusion injury[J]. Surgery, 2009, 146(2):181-189.
40	Yokota S, Yoshida O, Dou L, et al. IRF-1 promotes liver transplant ischemia/reperfusion injury via hepatocyte IL-15/IL-15Ralpha production[J]. J Immunol, 2015, 194(12):6045-6056.
41	Ueki S, Castellaneta A, Yoshida O, et al. Hepatic B7 homolog 1 expression is essential for controlling cold ischemia/reperfusion injury after mouse liver transplantation[J]. Hepatology, 2011, 54(1):216-228.

[1]	Dan Han, Ting Wang, Huan Xiao, Lirong Zhu, Jingyu Chen, Yi Tang. Diagnostic value of contrast enhanced ultrasound versus contrast enhanced computed tomography in benign and malignant liver lesions in children [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(09): 939-944.
[2]	Tingting Liu, Yanbing Lin, Shan Wang, Murong Chen, Zijian Tang, Dongling Dai, Bei Xia. Evaluation of metabolic dysfunction-associated fatty liver disease in children by ultrasound-guided attenuation parameter [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(08): 787-794.
[3]	Heng Lyu, Licong Dong, Haiqin Xie, Zhuofei Zhao, Li Liu, Desheng Sun. CT-ultrasound comparison for evaluating missed diagnosis of focal liver lesions by ultrasound: a single-center cross-sectional quality control survey [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(07): 712-716.
[4]	Xiaolin Ye, Yunfei Liu, Mingquan Pang, Haijiu Wang, Li Ren, Lizhao Hou, Wenhao Yu, Zhixin Wang, Haining Fan. Research progress on the sources and regulatory mechanisms of liver regenerative cells [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 96-99.
[5]	Xu Tang, Bing Han, Wei Liu, Ruxing Chen. Analysis of risk factors for metachronous liver metastases after radical colorectal cancer surgery and construction of a predictive model [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 16-20.
[6]	Qian Yang, Cuifang Li, Wanqiu Zhang. Analysis of short-term and long-term prognosis and influencing factors of primary liver cancer with spontaneous ruptured hemorrhage after emergency TACE surgery [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 33-36.
[7]	Jianmei Li, Jingjuan Deng, Qian Yang. Safety and follow-up evaluation of the combined treatment of hepatocellular carcinoma with hepatic cirrhosis and portal hypertension [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 41-44.
[8]	Fangyuan Wu, Xia Sun, Changfeng Lin, Zhensheng Zhang. Risk factors of HBV-associated cirrhosis complicated with acute upper gastrointestinal bleeding [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 45-47.
[9]	Xin Lu, Jiayi Xu, Yang Liu, Qin Yang, Wenwen Ju, Yinglong Xu. Comparison of the effects of early LC and PTCD continuous LC on liver function and prognosis of patients with acute cholecystitis [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 648-650.
[10]	LuoBu AChong, Ying Chen, Dekun Xie. Effect of laparoscopic complete exocyst dissection in the treatment of hepatic echinococcosis and its influence on liver function and prognosis [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 666-669.
[11]	Xian Mo, Chuang Yang. Meta-analysis of risk factors for portal vein thrombosis in patients with cirrhosis [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 678-683.
[12]	Xilin Du, Kai Tan, Xiaojun He. Conversion therapies for hepatocellular carcinoma [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(06): 597-601.
[13]	Xu Wang, Shaomin Shi, Yan Mao, Shang Ji, Yaling Liu. Metabolism of liver enzymes in osteoarthritis: a literature review [J]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2023, 09(06): 379-384.
[14]	Fanbiao Kong, Jianrong Yang. Progress in understanding of relationship between underlying liver diseases and liver metastasis of colorectal cancer [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(07): 818-822.
[15]	Daya Zhang, Shiju Chen, Runxiang Chen, Xiaodong Zhang, Da Li, Feihu Bai. Role of intestinal microecological dysregulation in development of metabolic-associated fatty liver disease [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(07): 828-833.

Please choose a citation manager

Content to export